Sign Up And Receive Our Latest Promotions!
.svg){kind=small}
4-8 May 2025
Salt Lake City
Visit our Booth #1031
Enhance ROI in your Clinical Trials with Artificial Intelligence
Join us at Eyecelerator and ARVO to learn how AI is transforming Clinical Trials by improving efficiency and patient enrollment. Explore how AI-powered pre-screening platforms are optimizing trial design, accelerating patient recruitment, and boosting trial success.
Experience Discovery CONNECT® — Live at ARVO!
See how effortlessly you can sync imaging data to RetinAI Discovery® in <30 seconds per image for smarter workflows, better clinical decisions and maximized efficiency.
Fully automated End-to-End Imaging Workflow with Topcon Triton
Join RetinAI and Topcon for an exclusive, hands-on demo of the most advanced, fully automated imaging workflow in eye care.
Live Demo Schedule at #Booth 1031
Smart Imaging Workflow for Enhanced Analysis with AI with Heidelberg Engineering’s SPECTRALIS
Join RetinAI and Heidelberg Engineering for a live showcase of the Smart Imaging Workflow — fully automating data upload, real-time image processing, and AI-powered analysis.
Connect with us at Eyecelerator!
🗓 Friday, 2nd May, 2025 📌 Grand Hyatt Deer Valley in Park City
Make sure to book the meeting in advance by clicking the button below.
Exclusive Ancillary Event
AI-Driven Imaging Solutions: Enhancing Efficiency and Candidate Selection in Clinical Trials
Hosted in collaboration with Topcon
🗓 Sunday, 4th May, 2025 ⏰ 6.00 PM MST 📌 Kimpton Hotel Monaco SLC
Join us for a one-of-a-kind session at ARVO, where leading retina specialists will highlight workflow design for revolutionizing the clinical trial process by leveraging functionality for automated data aggregation and the power of Artificial Intelligence (AI) on imaging based analysis on inclusion and exclusion criteria for studies in Retina.
Meet our Speakers
.png)
The program will focus on improving trial efficiency by automating image analysis, enabling faster and more enhanced identification of eligible candidates, to help reduce manual workloads. Through AI-based imaging solutions, the program aims to highlight the ability to:
- Accelerate Patient Candidate Identification: Utilize AI to analyze medical imaging data rapidly, identifying suitable candidates with greater precision.
- Optimize Trial Efficiency: Reduce time spent on candidate selection, leading to faster trial initiation and improved resource utilization.
- Improve Decision-Making: Provide objective, data-driven insights from imaging analysis to inform candidate selection before screening visits.
Don’t miss this exclusive opportunity to engage with top experts, exchange ideas, and gain valuable insights into the future of clinical trials.
Limited spots available—sign up now!
Posters co-authored by RetinAI
See Discovery platform and AI models featured in the following poster presentations from RetinAI's Team and Collaborators
4 May
Impact of acquisition device and quality control on test-retest repeatability of thickness measurements derived from OCT segmentation models
🕐 1:00 PM - 2:45 PM 👉 Add a bookmark in your calendar
📍Machine Learning for Segmentation and Other Applications I Poster Board 577 - A0214
📖 Read the abstract
6 May
Predicting Visual Sensitivity Loss in Eyes with Geographic Atrophy using OCT Imaging and Fundus Autofluorescence
🕐 8:30 AM - 10:15 AM 👉 Add a bookmark in your calendar
📍Clinical Applications in OCT I Poster Board 2793 - A0058
📖 Read the abstract
Translating nascent Geographic Atrophy definition into measurable biomarkers in OCT
🕐 1:15 PM - 3:00 PM 👉 Add a bookmark in your calendar
📍AMD 3 (imaging) I Poster Board 3491 - B0054
📖 Read the abstract
Impact of B-Scan Density on Accuracy of Geographic Atrophy Lesion Measurement in Optical Coherence Tomography
🕐 1:15 PM - 3:00 PM 👉 Add a bookmark in your calendar
📍AMD 3 (imaging) I Poster Board 3508 - B0071
📖 Read the abstract
Automatic OCT segmentation biomarkers for disease staging in Geographic Atrophy
🕐 3:30 PM - 5:15 PM 👉 Add a bookmark in your calendar
📍AI in epidemiology I Poster Board 3862 - B0399
📖 Read the abstract
Presentations using our Discovery Platform
See Discovery platform and AI models featured in the following poster presentations from the industry
5 May
Prediction of success and failure events during the journey of neovascular AMD treatments with anti-VEGF injections: a preliminary analysis.
🕐 3:00 - 4:45 PM
📍 AMD anti-VEGF II
📖 Read the abstract
Analysis of Optical Coherence Tomography Biomarkers in Diabetic Macular Edema: Baseline Characteristics and One-Year Outcomes After Intravitreal Therapy
🕐 8:30 - 10:15 AM
📍 AI in the Retina I
📖 Read the abstract
6 May
Ratio of Photoreceptor to Retinal Pigment Epithelium Atrophy at Baseline and Longitudinal Retinal Pigment Epithelium Atrophy Growth in Age-Related Macular Degeneration
🕐 8:30 - 10:15 AM
📍 Clinical Applications in OCT
📖 Read the abstract
Using artificial intelligence to assess macular edema in retinitis pigmentosa
🕐 8:30 - 10:15 AM
📍 Retinitis Pigmentosa and IRD II
📖 Read the abstract
AI analysis of OCT images from a Phase 1b study of ONL1204 Fas inhibition treatment for geographic atrophy secondary to age-related macular degeneration
🕐 1:15 - 3:00 PM
📍 AMD 3 (imaging) | Poster Board 3461 - B0024
📖 Read the abstract
Final results of the phase 2 BETTER trial using intravitreal ISTH0036, a selective TGF-β2 blocking antisense in nAMD and DME
🕐 3:30 - 5:15 PM
📍 AMD Clinical Research II
📖 Read the abstract
7 May
Correlation Between Contrast Sensitivity Function and OCT Biomarkers Among Patients with AMD
🕐 10:15 - 12:00 PM
📍 AMD 4 (clinical research)
📖 Read the abstract
Comparison of Multilayer Segmentation Thickness Results Between Two OCT Devices Using a Common Automated Algorithm
🕐 10:15 - 12:00 PM
📍 AI in the Retina II
📖 Read the abstract
Protein Changes Associated with Incomplete Response to Anti-VEGF Therapy in Diabetic Macular Edema – Integration of Proteomics and Artificial Intelligence
🕐 2:00 - 3:45 PM
📍 Diabetic Retinopathy Mechanisms and Preclinical Studies
📖 Read the abstract
Ikerian AG (HQ)
Freiburgstrasse 3
3010 Bern
Switzerland
RetinAI US Inc. (US)
6 Liberty Square
#2498 Boston, MA 02109
United States
Imprint/Legal Notice | Data Processing Agreement | Privacy Notice | Created by Ikerian AG. All rights reserved 2016-2023 ©